Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Start-Up Quarterly Statistics, Q3 2016

Executive Summary

A review of biopharma start-up dealmaking and financing from July through September 2016, based on data from Strategic Transactions.


Related Content

IPO Update: Novan, AC Immune End Summer Slowdown As Market Improves
Boehringer Gets Option To Buy ViraTherapeutics And Cancer Virus Therapy
Tech Transfer Roundup: Voyager Brings Home Pair Of CNS Collaborations
VC Roundup: Relay Raises $57m To Seek Drug Targets Among Proteins In Motion
VC Roundup: Moderna Seeks Another Record-Breaking Raise; Arcus Emerges From Stealth Mode
Denali Builds Neurodegeneration Pipeline Through Discovery, Collaborations And Lots Of Cash
Start-Up Quarterly Statistics, Q2 2016
VC Roundup: Cleave Raises $37m To Maintain Phase I Momentum, Plus $233.5m In Recent Financings
Jounce Gets $261m To Start, Milestone Fees Up To $2.3bn In Celgene Deal
Record CStone Funding Heralds New Era For China Startups


Related Companies